Javier G. Nevarez

Blackwell's Five-Minute Veterinary Consult: Reptile and Amphibian


Скачать книгу

MISCELLANEOUS

      COMMENTS

      N/A

      ZOONOTIC POTENTIAL

      Herpesviruses of reptiles have not been shown to be zoonotic.

      SYNONYMS

      Fibropapillomatosis (FP) in sea turtles

      ABBREVIATIONS

       chHV5 = chelonid alphaherpesvirus 5

       CNS = central nervous system

       ELISA = enzyme‐linked immunosorbent assay

       FPTHV = fibropapillomatosis‐associated turtle herpesvirus

       HV = herpesvirus

       LETD = lung = eye = and trachea disease

       LEDV = lung = eye = and trachea disease virus

       LGRV = loggerhead genital–respiratory herpesvirus

       LOCV = loggerhead orocutaneous herpesvirus

       PCR = polymerase chain reaction

       POTZ = preferred optimal temperature zone

       TeHV = testudinid herpesvirus

      1 Gandar F, Wilkie GS, Gatherer D, et al. The genome of a tortoise herpesvirus (testudinid herpesvirus 3) has a novel structure and contains a large region that is not required for replication in vitro or virulence in vivo. J Virol 2015;89(22):11438–11456.

      2 Marschang RE. Virology. In: Divers SJ, Stahl SJ, eds. Mader’s Reptile and Amphibian Medicine and Surgery. St. Louis, MO: Elsevier; 2019:247–269.

      3 Marschang RE. Viruses infecting reptiles. Viruses 2011;3:2087–2126.

      Author Rachel E. Marschang, PD, Dr. med. vet., DECZM (Herpetology), FTÄ Mikrobiologie

      Hexamita

      

BASICS

      DEFINITION/OVERVIEW

      Hexamita is a small flagellate parasite which can be found in the intestinal tract of chelonians and snakes. Hexamita parva is the usual cause of disease in chelonians. Disease has not been reported in other reptiles.

      ETIOLOGY/PATHOPHYSIOLOGY

       Infection is thought to occur by ingestion of an infective cyst, which passes into the gastrointestinal tract.

       Reproduction is by simple binary fission. Subsequently, the parasite may ascend via the bile ducts to the gall bladder or via the ureters to the kidneys, where it encysts, resulting in inflammation.

       Alternatively, Hexamita may pass through the gastrointestinal tract without resulting in disease.

       Transmission can occur via urine or feces.

      SIGNALMENT/HISTORY

       Disease has been described in a wide variety of chelonian species with no “typical” signalment.

      CLINICAL PRESENTATION

       Animals with Hexamita infection may be asymptomatic or have non‐specific signs such as lethargy and reduced appetite.

       If significant renal pathology is present, weight loss and polydipsia may be seen.

      RISK FACTORS

       Husbandry

      Poor hygiene will increase the risk of disease transmission.

       Others

      Pre‐existing renal or biliary disease or concurrent parasite infection have been suggested to be potential risk factors.

DIAGNOSIS

       Identification of the parasite in a sample of urine ± feces may lead to suspicion of disease, but flagellates are not always associated with pathology.

       Definitive diagnosis requires detection of the parasite on renal biopsy in a live animal.

      DIFFERENTIAL DIAGNOSIS

       Parasites should be distinguished from commensal intestinal flagellates, especially trichomonads, which may commonly be seen in fecal samples or urine samples contaminated with feces.

      DIAGNOSTICS

       Analysis of a fresh urine sample may reveal small fast‐moving flagellates (< 8 microns) characterized by six anterior flagella.

       In small samples the parasite will rapidly desiccate and die.

       Renal biopsies should be submitted for histopathology.

       Biochemistry may be helpful to indicate degree of renal damage.

      PATHOLOGICAL FINDINGS

       Characteristic postmortem findings include pale enlarged kidneys with dilated collecting tubules. Bile ducts appear thickened with a dilated lumen.

       On histopathological examination, flagellates may be visualized within the renal tubules and bile ducts with associated inflammatory changes.

TREATMENT

      APPROPRIATE HEALTH CARE

       Treatment involves both eliminating the parasite and supportive care of the renal disease.

       Euthanasia may be considered in severe cases of renal failure.

      NUTRITIONAL SUPPORT

       Some patients may be anorexic and severely dehydrated on presentation.

       Fluid deficits should always be corrected and nutritional support provided as needed.

      CLIENT EDUCATION/HUSBANDRY RECOMMENDATIONS

      Hygiene measures should be reviewed to minimize the risk of disease transmission.

MEDICATIONS

      DRUG(S) OF CHOICE

       Metronidazole is the most common choice for treating Hexamita.

       Various